Related Experiment Video
Updated: Oct 27, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Accelerated T2-Weighted TSE Imaging of the Prostate Using Deep Learning Image Reconstruction: A Prospective
Sebastian Gassenmaier1, Saif Afat1, Marcel Dominik Nickel2
1Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Hoppe-Seyler-Straße 3, 72076 Tuebingen, Germany.
Deep learning image reconstruction (DLR) significantly improves prostate MRI quality and diagnostic confidence while reducing scan time by over 60%. This advanced technique enhances lesion conspicuity in T2-weighted imaging for better prostate cancer evaluation.
Area of Science:
- Radiology
- Medical Imaging
- Artificial Intelligence
Background:
- Multiparametric MRI (mpMRI) is standard for prostate cancer evaluation.
- Deep learning image reconstruction (DLR) shows promise for accelerating MRI scans.
Purpose of the Study:
- To assess the impact of DLR on T2-weighted TSE prostate MRI.
- To evaluate image quality, diagnostic confidence, PI-RADS, and T2 scoring with DLR compared to standard imaging.
Main Methods:
- Prospective study of 60 patients undergoing 3T mpMRI for prostate cancer.
- Acquisition of standard T2 TSE (T2S) and DLR-enhanced T2 TSE (T2DLR) sequences.
- Independent radiologist evaluation of image quality, artifacts, conspicuity, and scoring using a Likert scale.
Main Results:
- DLR reduced acquisition time by over 60% (10:21 min vs. 3:50 min).
- DLR significantly improved noise levels, reduced artifacts, and enhanced overall image quality and lesion conspicuity.
- Both readers found superior image quality and lesion conspicuity with T2DLR compared to T2S.
Conclusions:
- T2-weighted TSE prostate MRI with DLR is feasible, reducing scan time significantly.
- DLR offers substantial improvements in image quality and diagnostic confidence for prostate cancer evaluation.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
15:48Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014